Back to Search Start Over

Preliminary experience with a hybrid nonthoracotomy defibrillating system that includes a biphasic device: Comparison with a standard monophasic device using the same lead system

Authors :
Jasbir Sra
Sanjay Deshpande
Kathi Axtell
Cheryl Maglio
Andrea Natale
Mohammad Jazayeri
Anwer Dhala
Masood Akhtar
Abdul Wase
Source :
Journal of the American College of Cardiology. (2):406-412
Publisher :
Published by Elsevier Inc.

Abstract

Objectives. This study analyzed the advantage of combining a biphasic device with a transvenous system and compared the results with those obtained with a standard monophasic device. Background. Available lead system use monophasic pulses and may require lengthy intraoprative testing to achieve adequate defibrillation threshold in a conspicuous number of patients. The option of biphasis waveform may provide further benefits. However, clinical experience with a permanent implant is lacking. Methods. Fifty-five patients underwent testing and received a permanent implant using the Endotak lead system associated with a CPI monophasic device. The remaining 36 patients received a permanent implant with the Endotak lead system connected to a biphasic device. In both groups a subcutaneous patch was combined when needed to obtain acceptable defibrillation thresholds. Results. Biphasic pulses resulted in lower mean (±SD) defibrillation threshold (monophasic 15 ± 4.7 J vs. biphasic 12 ± 5 J, p = 0.03) and a better implantation rate (100% biphasic vs. 89% monophasic, p = 0.07). Biphasic pulses allowed implantation with less ventricular fibrillation induction (7.4 ± 3.2 vs. 3.5 ± 1.8, p < 0.01) and a mean shorter procedure time (168 ± 39 vs. 111 ± 30 min, p < 0.01). With the biphasic waveform a grater proportion of patients met the implantation criteria with the lead system alone (83% vs. 45%, p < 0.01). When needed, the left prepectoral location of the patch electrode was always sufficient in patients receiving the biphasic device, whereas placement in the left subscapular position was required in 15 patients in the monophaisic group. Implantation of the biphasic device was associated with a shorter mean hospital stay (3.8 ± 0.8 vs. 5.4 ± 2.2 days, p < 0.01). Conclusions. Incorporation of a biphasic device in a transvenous implantable cardioverter-defibrillator uniformly incresses the efficacy of the system and the case of implantation.

Details

Language :
English
ISSN :
07351097
Issue :
2
Database :
OpenAIRE
Journal :
Journal of the American College of Cardiology
Accession number :
edsair.doi.dedup.....81ca9377dc582c7cf3ffb409d52f6ca0
Full Text :
https://doi.org/10.1016/0735-1097(94)90295-X